Table 3 Human papillomavirus (HPV) by age and human immunodeficiency (HIV) status in men
| Â | All men | HIV-positive men | HIV-negative men | P-valuea |
|---|---|---|---|---|
N = 471 | N = 158 | N = 313 |  | |
Any HPV | ||||
 All men | 59.4 % (280/471) | 76.6 % (121/158) | 50.8 % (159/313) | <0.0001 |
  18–25 years | 79.1 % (34/43) | 87.5 % (7/8) | 77.1 % (27/35) | 0.535 |
  26–35 years | 60.9 % (95/156) | 77.8 % (49/63) | 49.5 % (46/93) | 0.0004 |
  36–45 years | 60.5 % (101/167) | 75.8 % (50/66) | 50.5 % (51/101) | 0.001 |
  46–66 years | 47.6 % (50/105) | 71.4 % (15/21) | 41.7 % (35/84) | 0.015 |
Multiple HPV infections | ||||
 All men | 41.0 % (193/471) | 62.7 % (99/158) | 30.0 % (94/313) | <0.0001 |
  18–25 years | 55.8 % (24/43) | 87.5 % (7/8) | 48.6 % (17/35) | 0.050 |
  26–35 years | 44.2 % (69/156) | 68.3 % (43/63) | 28.0 % (26/93) | <0.0001 |
  36–45 years | 41.3 % (69/167) | 59.1 % (39/66) | 29.7 % (30/101) | 0.0002 |
  46–66 years | 29.5 % (31/105) | 47.6 % (10/21) | 25.0 % (21/84) | 0.041 |
Single HPV infection | ||||
 All men | 18.5 % (87/471) | 13.9 % (22/158) | 20.8 % (65/313) | 0.071 |
  18–25 years | 23.3 % (10/43) | 0.0 % (0/8) | 28.6 % (10/35) | … |
  26–35 years | 35.9 % (56/156) | 9.5 % (6/63) | 21.5 % (20/93) | 0.050 |
  36–45 years | 19.2 % (32/167) | 16.7 % (11/66) | 20.8 % (21/101) | 0.511 |
  46–66 years | 18.1 % (19/105) | 23.8 % (5/21) | 16.7 % (14/84) | 0.453 |
HR-HPV | ||||
 All men | 19.7 % (93/471) | 54.4 % (86/158) | 22.4 % (70/313) | <0.0001 |
  18–25 years | 48.8 % (21/43) | 75.0 % (6/8) | 42.9 % (15/35) | 0.109 |
  26–35 years | 39.1 % (61/156) | 61.9 % (39/63) | 23.7 % (22/93) | <0.0001 |
  36–45 years | 32.9 % (55/167) | 50.0 % (33/66) | 21.8 % (22/101) | 0.0002 |
  46–66 years | 21.0 % (22/105) | 28.6 % (6/21) | 19.0 % (16/84) | 0.343 |
Probable HR-HPV | ||||
 All men | 16.1 % (76/471) | 54.4 % (86/158) | 20.8 % (65/313) | <0.0001 |
  18–25 years | 41.9 % (18/43) | 62.5 % (5/8) | 37.1 % (13/35) | 0.201 |
  26–35 years | 28.2 % (44/156) | 44.4 % (28/63) | 17.2 % (16/93) | 0.0002 |
  36–45 years | 29.9 % (50/167) | 31.8 % (21/66) | 28.7 % (29/101) | 0.671 |
  46–66 years | 15.2 % (16/105) | 42.9 % (9/21) | 8.3 % (7/84) | <0.0001 |
LR-HPV | ||||
 All men | 29.5 % (139/471) | 63.9 % (101/158) | 33.2 % (104/313) | <0.0001 |
  18–25 years | 53.5 % (23/43) | 75.0 % (6/8) | 48.6 % (17/35) | 0.187 |
  26–35 years | 37.8 % (59/156) | 66.7 % (42/63) | 18.3 % (17/93) | <0.0001 |
  36–45 years | 47.9 % (80/167) | 59.1 % (39/66) | 40.6 % (41/101) | 0.020 |
  46–66 years | 41.0 % (43/105) | 66.7 % (14/21) | 34.5 % (29/84) | 0.008 |